Advertisement

Obesity in Adolescents with Psychiatric Disorders

  • Ariana M. Chao
  • Thomas A. Wadden
  • Robert I. BerkowitzEmail author
Child and Adolescent Disorders (T Benton, Section Editor)
  • 139 Downloads
Part of the following topical collections:
  1. Topical Collection on Child and Adolescent Disorders

Abstract

Purpose of Review

This narrative review synthesized recent research related to obesity in adolescents with psychiatric disorders, with a focus on epidemiology, mechanisms, and weight management approaches. The paper reviews literature on depressive and anxiety disorders, bipolar disorder, and schizophrenia spectrum and other psychotic disorders.

Recent Findings

Depression has a bidirectional relationship with obesity. Bipolar disorder and schizophrenia spectrum disorders, and their treatments, increase the risk of developing obesity. Mechanisms underlying this weight gain include lifestyle and environmental factors and psychiatric medications, though emerging evidence has also suggested the role of genetic and neuroendocrine processes. Evidence about the most effective treatments for obesity in adolescents with psychiatric disorders remains limited.

Summary

Adolescents with psychiatric disorders are at high risk for obesity. Close monitoring for increases in weight and cardiometabolic risk factors with use of antipsychotic and mood-stabilizing medications is recommended. Clinical trials are needed that test the efficacy of weight management strategies for this population.

Keywords

Adolescence Obesity Psychiatric disorders Depression Bipolar disorder Schizophrenia 

Notes

Funding

Ariana M. Chao was supported, in part, by the National Institute of Nursing Research of the National Institutes of Health under Award Number K23NR017209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Compliance with Ethical Standards

Conflict of Interest

Ariana M. Chao reports grants and personal fees from Shire Pharmaceuticals, outside the submitted work.

Thomas A. Wadden reports grants and personal fees from Novo Nordisk, grants from Eisai Pharmaceuticals, and personal fees from Weight Watchers, outside the submitted work.

Robert I. Berkowitz reports a research grant and personal fees from Eisai Inc., outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease—a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Ösby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844–50.PubMedGoogle Scholar
  4. 4.
    Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis. 2003;191(12):799–805.PubMedGoogle Scholar
  6. 6.
    Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341–50.PubMedGoogle Scholar
  7. 7.
    Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017.Google Scholar
  8. 8.
    Centers for Disease Control Prevention. Clinical Growth Charts. 2017. https://www.cdc.gov/growthcharts/clinical_charts.htm. Accessed July 26 2018.
  9. 9.
    Simmonds M, Llewellyn A, Owen C, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17(2):95–107.PubMedGoogle Scholar
  10. 10.
    Ode KL, Frohnert BI, Nathan BM. Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord. 2009;10(3):167–88.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol. 2014;6(3):129–43.PubMedGoogle Scholar
  12. 12.
    Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373(14):1307–17.PubMedGoogle Scholar
  13. 13.
    Xanthopoulos MS, Gallagher PR, Berkowitz RI, Radcliffe J, Bradford R, Marcus CL. Neurobehavioral functioning in adolescents with and without obesity and obstructive sleep apnea. Sleep. 2015;38(3):401–10.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Nadeau KJ, Maahs DM, Daniels SR, Eckel RH. Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol. 2011;8(9):513–25.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Fleischhaker C, Heiser P, Hennighausen K, Herpertz-Dahlmann B, Holtkamp K, Mehler-Wex C, et al. Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone. J Neural Transm. 2008;115(11):1599–608.PubMedGoogle Scholar
  16. 16.
    Marmorstein NR, Iacono WG, Legrand L. Obesity and depression in adolescence and beyond: reciprocal risks. Int J Obes. 2014;38(7):906–11.Google Scholar
  17. 17.
    •• Quek YH, Tam WW, Zhang MW, Ho R. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes Rev. 2017;18(7):742–54 This meta-analysis includes 18 observational studies examining the relationship between obesity and depression. PubMedGoogle Scholar
  18. 18.
    •• Mannan M, Mamun A, Doi S, Clavarino A. Prospective associations between depression and obesity for adolescent males and females—a systematic review and meta-analysis of longitudinal studies. PLoS One. 2016;11(6):e0157240 This meta-analysis includes 13 longitudinal studies assessing the bidirectional relationship between obesity and depression.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Zeller MH, Reiter-Purtill J, Jenkins TM, Ratcliff MB. Adolescent suicidal behavior across the excess weight status spectrum. Obesity. 2013;21(5):1039–45.PubMedGoogle Scholar
  20. 20.
    van Dam RM, Willett WC, Manson JE, Hu FB. The relationship between overweight in adolescence and premature death in women. Ann Intern Med. 2006;145(2):91–7.PubMedGoogle Scholar
  21. 21.
    Roberts RE, Duong HT. Do anxiety disorders play a role in adolescent obesity? Ann Behav Med. 2016;50(4):613–21.PubMedGoogle Scholar
  22. 22.
    Jensen KG, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, et al. Pretreatment cardiometabolic status in youth with early-onset psychosis: baseline results from the TEA trial. J Clin Psychiatry. 2017;78(8):e1035–e46.PubMedGoogle Scholar
  23. 23.
    • Bioque M, García-Portilla MP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, et al. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. Schizophr Res. 2018;193:188–96 This study examined weight gain and metabolic changes in a cohort of patients with FEP over 2 years.PubMedGoogle Scholar
  24. 24.
    Calkin C, Van De Velde C, Růžičková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord. 2009;11(6):650–6.PubMedPubMedCentralGoogle Scholar
  25. 25.
    McElroy SL, Kemp DE, Friedman ES, Reilly-Harrington NA, Sylvia LG, Calabrese JR, et al. Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016;133(2):144–53.PubMedGoogle Scholar
  26. 26.
    • Goldstein BI, Blanco C, He J-P, Merikangas K. Correlates of overweight and obesity among adolescents with bipolar disorder in the National Comorbidity Survey–Adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2016;55(12):1020–6 This study examines the relationship of overweight/obesity in a nationally representaive sample of adolescents with bipolar disorder, major depressive disorder, and control using face-to-face surveys.PubMedGoogle Scholar
  27. 27.
    Hu C, Torres IJ, Qian H, Wong H, Halli P, Dhanoa T, et al. Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord. 2017;208:291–7.PubMedGoogle Scholar
  28. 28.
    Shapiro J, Mindra S, Timmins V, Swampillai B, Scavone A, Collinger K, et al. Controlled study of obesity among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2017;27(1):95–100.PubMedGoogle Scholar
  29. 29.
    Mooreville M, Shomaker LB, Reina SA, Hannallah LM, Cohen LA, Courville AB, et al. Depressive symptoms and observed eating in youth. Appetite. 2014;75:141–9.PubMedPubMedCentralGoogle Scholar
  30. 30.
    O’Neil A, Quirk SE, Housden S, Brennan SL, Williams LJ, Pasco JA, et al. Relationship between diet and mental health in children and adolescents: a systematic review. Am J Public Health. 2014;104(10):e31–42.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Skinner HH, Haines J, Austin SB, Field AE. A prospective study of overeating, binge eating, and depressive symptoms among adolescent and young adult women. J Adolesc Health. 2012;50(5):478–83.PubMedGoogle Scholar
  32. 32.
    Martin K, Woo J, Timmins V, Collins J, Islam A, Newton D, et al. Binge eating and emotional eating behaviors among adolescents and young adults with bipolar disorder. J Affect Disord. 2016;195:88–95.PubMedGoogle Scholar
  33. 33.
    Hoare E, Millar L, Fuller-Tyszkiewicz M, Skouteris H, Nichols M, Malakellis M, et al. Depressive symptomatology, weight status and obesogenic risk among Australian adolescents: a prospective cohort study. BMJ Open. 2016;6(3):e010072.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Castillo F, Francis L, Wylie-Rosett J, Isasi CR. Depressive symptoms are associated with excess weight and unhealthier lifestyle behaviors in urban adolescents. Child Obes. 2014;10(5):400–7.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Goldfield GS, Murray M, Maras D, Wilson AL, Phillips P, Kenny GP, et al. Screen time is associated with depressive symptomatology among obese adolescents: a HEARTY study. Eur J Pediatr. 2016;175(7):909–19.PubMedGoogle Scholar
  36. 36.
    Rankin J, Matthews L, Cobley S, Han A, Sanders R, Wiltshire HD, et al. Psychological consequences of childhood obesity: psychiatric comorbidity and prevention. Adolesc Health Med Ther. 2016;7:125–46.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Kaushik A, Kostaki E, Kyriakopoulos M. The stigma of mental illness in children and adolescents: a systematic review. Psychiatry Res. 2016;243:469–94.PubMedGoogle Scholar
  38. 38.
    Stevens SD, Herbozo S, Morrell HE, Schaefer LM, Thompson JK. Adult and childhood weight influence body image and depression through weight stigmatization. J Health Psychol. 2017;22(8):1084–93.PubMedGoogle Scholar
  39. 39.
    Quinlan NP, Hoy MB, Costanzo PR. Sticks and stones: the effects of teasing on psychosocial functioning in an overweight treatment-seeking sample. Soc Dev. 2009;18(4):978–1001.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Gerke CK, Mazzeo SE, Stern M, Palmberg AA, Evans RK, Wickham EP III. The stress process and eating pathology among racially diverse adolescents seeking treatment for obesity. J Pediatr Psychol. 2013;38(7):785–93.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med. 2015;45(1):11–27.PubMedGoogle Scholar
  42. 42.
    Puhl RM, Peterson JL, Luedicke J. Parental perceptions of weight terminology that providers use with youth. Pediatrics. 2011;128(4):e786–93.PubMedGoogle Scholar
  43. 43.
    Raben AT, Marshe VS, Chintoh A, Gorbovskaya I, Müller DJ, Hahn M. The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment. Front Neurosci. 2017;11:741.PubMedGoogle Scholar
  44. 44.
    •• Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M et al. First-and second-generation antipsychotics in children and young adults: systematic review update. Rockville (MD): Agency for Healthcare Research and Quality; 2017 Contract No.: 17-EHC001-EF. This provides a comprehensive review of first-and second generation antipsychotics in children and young adults.Google Scholar
  45. 45.
    Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–23.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T, Canadian Alliance for Monitoring Effectiveness, et al. Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth. Paediatr Child Health. 2011;16(9):575–80.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Bushe CJ, Slooff CJ, Haddad PM, Karagianis JL. Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database. J Clin Psychiatry. 2012;73(6):e749–55.PubMedGoogle Scholar
  48. 48.
    •• Pillay J, Boylan K, Newton A, Hartling L, Vandermeer B, Nuspl M et al. Harms of antipsychotics in children and young adults: a systematic review update. Can J Psychiatry. 2018. This included 135 studies on the harms of first- and second-generation treatment of psychiatric conditions in youth, and includes a review of these medications on weight gain.Google Scholar
  49. 49.
    Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, DeThomas C, Kafantaris V, et al. Clozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry. 2008;63(5):524–9.PubMedGoogle Scholar
  50. 50.
    Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–73.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Martínez-Ortega JM, Funes-Godoy S, Díaz-Atienza F, Gutiérrez-Rojas L, Pérez-Costillas L, Gurpegui M. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. Eur Child Adolesc Psychiatry. 2013;22(8):457–79.PubMedGoogle Scholar
  52. 52.
    • Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Chaimani A, et al. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis. Eur Neuropsychopharmacol. 2018;28(6):659–74 This network meta-analysis synthesizes data from 28 randomized controlled trials comparing symptoms of schizophrenia in youth including weight gain.PubMedGoogle Scholar
  53. 53.
    Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004;161(3):414–25.PubMedGoogle Scholar
  54. 54.
    Bai YM, Lin C-C, Chen J-Y, Lin C-Y, Su T-P, Chou P. Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry. 2006;163(7):1276–9.PubMedGoogle Scholar
  55. 55.
    Kemp DE, Correll CU, Tohen M, DelBello MP, Ganocy SJ, Findling RL, et al. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia. J Child Adolesc Psychopharmacol. 2013;23(8):522–30.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Srihari VH, Phutane VH, Ozkan B, Chwastiak L, Ratliff JC, Woods SW, et al. Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr Res. 2013;146(1):64–8.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Zhang J-P, Lencz T, Zhang RX, Nitta M, Maayan L, John M, et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr Bull. 2016;42(6):1418–37.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Jerrell JM, McIntyre RS. Metabolic, digestive, and reproductive adverse events associated with antimanic treatment in children and adolescents: a retrospective cohort study. Prim Care Companion J Clin Psychiatry. 2010;12(4):e1–8.Google Scholar
  59. 59.
    Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry. 2007;46(6):687–700.PubMedGoogle Scholar
  60. 60.
    Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515–28.PubMedGoogle Scholar
  61. 61.
    Reekie J, Hosking S, Prakash C, Kao KT, Juonala M, Sabin M. The effect of antidepressants and antipsychotics on weight gain in children and adolescents. Obes Rev. 2015;16(7):566–80.PubMedGoogle Scholar
  62. 62.
    Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003;290(8):1033–41.PubMedGoogle Scholar
  63. 63.
    Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48(7):721–9.PubMedGoogle Scholar
  64. 64.
    Schwartz BS, Glass TA, Pollak J, Hirsch AG, Bailey-Davis L, Moran TH, et al. Depression, its comorbidities and treatment, and childhood body mass index trajectories. Obesity. 2016;24(12):2585–92.PubMedGoogle Scholar
  65. 65.
    Cockerill RG, Biggs BK, Oesterle TS, Croarkin PE. Antidepressant use and body mass index change in overweight adolescents: a historical cohort study. Innov Clin Neurosci. 2014;11(11–12):14–21.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry. 2014;71(8):889–96.PubMedGoogle Scholar
  67. 67.
    Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119–36.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Afari N, Noonan C, Goldberg J, Roy-Byrne P, Schur E, Golnari G, et al. Depression and obesity: do shared genes explain the relationship? Depress Anxiety. 2010;27(9):799–806.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7(1):e1007.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Milaneschi Y, Lamers F, Peyrot WJ, Baune BT, Breen G, Dehghan A, et al. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 2017;74(12):1214–25.PubMedGoogle Scholar
  71. 71.
    Zelinski EL, Deibel SH, McDonald RJ. The trouble with circadian clock dysfunction: multiple deleterious effects on the brain and body. Neurosci Biobehav Rev. 2014;40:80–101.PubMedGoogle Scholar
  72. 72.
    Lu X-Y. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007;7(6):648–52.PubMedPubMedCentralGoogle Scholar
  73. 73.
    Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;45:92–9.Google Scholar
  74. 74.
    Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, et al. Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth. Can J Psychiatry. 2017;62(9):635–47.PubMedPubMedCentralGoogle Scholar
  75. 75.
    •• The National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. 2013. https://www.nice.org.uk/guidance/cg155. Accessed July 26 2018. These are clinical guidelines about the management of psychosis and schizophrenia in children and young people.
  76. 76.
  77. 77.
    McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107–25.PubMedGoogle Scholar
  78. 78.
    American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601.Google Scholar
  79. 79.
    Hasnain M, Vieweg WVR. Weight considerations in psychotropic drug prescribing and switching. Postgrad Med. 2013;125(5):117–29.PubMedGoogle Scholar
  80. 80.
    Grossman DC, Bibbins-Domingo K, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417–26.PubMedGoogle Scholar
  81. 81.
    Berkowitz RI, Rukstalis MR, Bishop-Gilyard CT, Moore RH, Gehrman CA, Xanthopoulos MS, et al. Treatment of adolescent obesity comparing self-guided and group lifestyle modification programs: a potential model for primary care. J Pediatr Psychol. 2013;38(9):978–86.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Teasdale SB, Ward PB, Rosenbaum S, Samaras K, Stubbs B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry. 2016;210(2):110–8.PubMedGoogle Scholar
  83. 83.
    Naslund JA, Whiteman KL, McHugo GJ, Aschbrenner KA, Marsch LA, Bartels SJ. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2017;47:83–102.PubMedPubMedCentralGoogle Scholar
  84. 84.
    • Teasdale SB, Ward PB, Rosenbaum S, Watkins A, Curtis J, Kalucy M, et al. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis. Br J Nutr. 2016;115(11):1987–93 This study evaluated the feasibility and effectiveness of a 12-week nutrition intervention in participants ages 15–25 years with FEP.PubMedGoogle Scholar
  85. 85.
    Ignaszewski MJ, Waslick B. Update on randomized placebo-controlled trials in the past decade for treatment of major depressive disorder in child and adolescent patients: a systematic review. J Child Adolesc Psychopharmacol. 2018;28:668–75.Google Scholar
  86. 86.
    Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep. 2015;17(7):52.PubMedGoogle Scholar
  87. 87.
    Stafford MR, Mayo-Wilson E, Loucas CE, James A, Hollis C, Birchwood M, et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117166.PubMedPubMedCentralGoogle Scholar
  88. 88.
    Goldstein BI, Sassi R, Diler RS. Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatric Clin. 2012;21(4):911–39.Google Scholar
  89. 89.
    Haas M, Eerdekens M, Kushner S, Singer J, Augustyns I, Quiroz J, et al. Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study. Br J Psychiatry. 2009;194(2):158–64.PubMedGoogle Scholar
  90. 90.
    Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry. 2006;163(3):402–10.PubMedGoogle Scholar
  91. 91.
    Chao AM, Wadden TA, Berkowitz RI. The safety of pharmacologic treatment for pediatric obesity. Expert Opin Drug Saf. 2018;17(4):379–85.PubMedGoogle Scholar
  92. 92.
    Chanoine J-P, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.PubMedGoogle Scholar
  93. 93.
    de Silva VA, Suraweera C, Ratnatunga SS, Dayabandara M, Wanniarachchi N, Hanwella R. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16(1):341.PubMedPubMedCentralGoogle Scholar
  94. 94.
    • Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry. 2006;163(12):2072–9 This is a small, 16-week placebo-controlled trial demonstating the safety and efficacy of metformin in youth taking second-generation antipsychotics.PubMedGoogle Scholar
  95. 95.
    ClinicalTrials.gov. Metformin for overweight & obese children and adolescents with BDS treated with SGAs (MOBILITY). 2017. https://clinicaltrials.gov/ct2/show/NCT02515773. Accessed July 25 2018.
  96. 96.
    Pratt JS, Lenders CM, Dionne EA, Hoppin AG, Hsu GL, Inge TH, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity. 2009;17(5):901–10.PubMedGoogle Scholar
  97. 97.
    Herget S, Rudolph A, Hilbert A, Blüher S. Psychosocial status and mental health in adolescents before and after bariatric surgery: a systematic literature review. Obes Facts. 2014;7(4):233–45.PubMedPubMedCentralGoogle Scholar
  98. 98.
    Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114(1):217–23.PubMedGoogle Scholar
  99. 99.
    Mackey ER, Wang J, Harrington C, Nadler EP. Psychiatric diagnoses and weight loss among adolescents receiving sleeve gastrectomy. Pediatrics. 2018:e20173432.Google Scholar
  100. 100.
    Njoroge WF, Hostutler CA, Schwartz BS, Mautone JA. Integrated behavioral health in pediatric primary care. Curr Psychiatry Rep. 2016;18(12):106.PubMedGoogle Scholar
  101. 101.
    Hilt R, Marx L, Pierce K, Sarvet B, Becker E, Kendrick J et al. A guide to building collaborative mental health care partnerships in pediatric primary care. 2010.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ariana M. Chao
    • 1
    • 2
  • Thomas A. Wadden
    • 2
  • Robert I. Berkowitz
    • 2
    • 3
    Email author
  1. 1.Department of Biobehavioral Health SciencesUniversity of Pennsylvania School of NursingPhiladelphiaUSA
  2. 2.Department of PsychiatryPerelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  3. 3.Department of Child and Adolescent Psychiatry and Behavioral SciencesChildren’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations